TGFB1 and Marfan syndrome: The dimorphic effects of TGF-β, particulary that early inhibition exacerbates TAA formation, provides an increased rationale for this study to identify new biomarkers and therapies independent of the TGF-β signaling pathway, such as KLF4, to better understand the early developmental changes in Marfan’s Syndrome.